Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)
SkinJect, Inc.
SkinJect, Inc.
Regeneron Pharmaceuticals
Incyte Corporation
Senhwa Biosciences, Inc.
TuHURA Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
Xencor, Inc.
Novartis
Novartis
Novartis
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Genentech, Inc.
Blaze Bioscience Australia Pty Ltd
Bristol-Myers Squibb
Millennium Pharmaceuticals, Inc.